The stock market tumbled last week, led by highly valued growth plays such as Palantir and Tesla. Nvidia earnings loom.
The aerospace giant's loss may be other companies' gain, with SpaceX and Blue Origin among the prime potential beneficiaries.
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as a buy.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
My next stock market buy’s likely to be in the FTSE 250, and I'm looking for shares I think can pay progressive long-term ...
Analysts believe bank stocks have entered a new era where even the slightest surprise triggers an outsized reaction by ...
Exhausted buying enthusiasm, followed by intense selling, can trigger a market correction or meltdown. Check out the past ...
Quantum computing could be the next big thing in tech after artificial intelligence (AI). If you want ideas about which ...